insights_auto
Why is TNXP down 9.57%?
Dive Deeperchevron_right
TNXP:NASDAQ
Tonix Pharmaceuticals Holding Corp
$2.55
arrow_downward
-9.57%(-0.27) 1D
$2.58
arrow_upward
+1.18% (+0.030)todayPre-market
Closed: Nov 19, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TNXP...
Open
$2.83
High
$2.84
Low
$2.52
Mkt. cap
49.55M
Avg. vol.
1.11M
Volume
262.00
52-wk high
$20.56
52-wk low
$2.52
EPS
-$12.23
Beta
1.90
Shares outstanding
19.43M
No. of employees
142
Open
$2.83
High
$2.84
Low
$2.52
Mkt. cap
49.55M
Avg. vol.
1.11M
Volume
262.00
52-wk high
$20.56
52-wk low
$2.52
EPS
-$12.23
Beta
1.90
Shares outstanding
19.43M
No. of employees
142
News stories
From web sources and news partners
Bloomberg.com
·
38 minutes ago
Stock Rout’s Spread Beyond Tech Carries Warning From Dotcom-Era
Yahoo Finance
·
1 hour ago
SPDR S&P 500 ETF (SPY) Sells Apple and Microsoft on Nov. 18
Rich Picks Daily
·
29 minutes ago
Nasdaq Composite lost 0.6% as AI-sector unease persisted despite Anthr…
Profile
Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project. Wikipedia
About Tonix Pharmaceuticals Holding Corp
CEOSeth Lederman
Employees142
Founded2007
HeadquartersBerkeley Heights, New Jersey, United States
SectorHealth Care
IndustryBiotechnology
Websitetonixpharma.com